Collegium [COLL] vs Zoetis [ZTS] Detailed Stock Comparison

Collegium Pharmaceutical Inc.

NASDAQ
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Collegium Pharmaceutical Inc. wins in 9 metrics, Zoetis Inc. wins in 11 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Collegium Pharmaceutical Inc. Zoetis Inc. Better
P/E Ratio (TTM) 18.79 19.58 Collegium Pharmaceutical Inc.
Price-to-Book Ratio 3.42 15.04 Collegium Pharmaceutical Inc.
Debt-to-Equity Ratio 310.41 279.59 Zoetis Inc.
PEG Ratio 0.49 2.81 Collegium Pharmaceutical Inc.
EV/EBITDA 3.77 13.96 Collegium Pharmaceutical Inc.
Profit Margin (TTM) 8.05% 28.24% Zoetis Inc.
Operating Margin (TTM) 30.04% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 30.04% 34.69% Zoetis Inc.
Return on Equity 23.70% 65.99% Zoetis Inc.
Return on Assets (TTM) 7.27% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $327.58M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return 15.34% -53.93% Collegium Pharmaceutical Inc.
Price-to-Sales Ratio (TTM) 1.35 5.26 Collegium Pharmaceutical Inc.
Enterprise Value $1.58B $56.75B Zoetis Inc.
EV/Revenue Ratio 2.03 6.00 Collegium Pharmaceutical Inc.
Gross Profit Margin (TTM) 62.49% 70.17% Zoetis Inc.
Revenue per Share (TTM) $25 $21 Collegium Pharmaceutical Inc.
Earnings per Share (Diluted) $1.73 $6.02 Zoetis Inc.
Beta (Stock Volatility) 0.77 0.97 Collegium Pharmaceutical Inc.
Short % of Float 22.26% 4.06% Zoetis Inc.

Collegium Pharmaceutical Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

COLL
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Collegium Pharmaceutical Inc.1.90%-7.78%-10.18%-22.33%-35.09%-31.78%
Zoetis Inc.1.51%-4.46%-31.75%-39.76%-38.95%-38.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Collegium Pharmaceutical Inc.15.34%55.39%54.10%108.37%159.54%159.54%
Zoetis Inc.-53.93%-54.80%-55.66%62.09%150.53%150.53%

Performance & Financial Health Analysis: Collegium Pharmaceutical Inc. vs Zoetis Inc.

MetricCOLLZTS
Market Information
Market Cap i$1.05B$49.75B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i492,2202,727,710
90 Day Avg. Volume i584,0773,835,940
Last Close$31.06$167.10
52 Week Range$28.90 - $50.79$139.70 - $200.33
% from 52W High-38.84%-16.59%
All-Time High$50.79 (Dec 29, 2025)$249.27 (Dec 27, 2021)
% from All-Time High-38.85%-32.96%
Growth Metrics
Quarterly Revenue Growth0.13%0.03%
Quarterly Earnings Growth0.35%0.04%
Financial Health
Profit Margin (TTM) i0.08%0.28%
Operating Margin (TTM) i0.30%0.35%
Return on Equity (TTM) i0.24%0.66%
Debt to Equity (MRQ) i310.41279.59
Cash & Liquidity
Book Value per Share (MRQ)$9.51$7.84
Cash per Share (MRQ)$12.18$5.48
Operating Cash Flow (TTM) i$329.32M$2.90B
Levered Free Cash Flow (TTM) i$321.54M$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend iN/A$2.03

Valuation & Enterprise Metrics Analysis: Collegium Pharmaceutical Inc. vs Zoetis Inc.

MetricCOLL (Apr 26, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i18.7919.58
Forward P/E i4.8215.61
PEG Ratio i0.492.81
Price to Sales (TTM) i1.355.26
Price to Book (MRQ) i3.4215.04
Market Capitalization
Market Capitalization i$1.05B$49.75B
Enterprise Value i$1.58B$56.75B
Enterprise Value Metrics
Enterprise to Revenue i2.036.00
Enterprise to EBITDA i3.7713.96
Risk & Other Metrics
Beta i0.770.97
Book Value per Share (MRQ) i$9.51$7.84

Financial Statements Comparison: Collegium Pharmaceutical Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOLL (2025)ZTS (2025)
Revenue/Sales i780.57M9.47B
Cost of Goods Sold i317.31M2.67B
COGS % of Revenue i40.7%28.2%
Gross Profit i463.26M6.80B
Gross Margin i59.3%71.8%
Research & Development iN/A698.00M
Operating Income (EBIT) i178.45M3.60B
Operating Margin i22.9%38.0%
EBITDA i415.82M4.17B
EBITDA Margin i53.3%44.1%
Pre-Tax Income i92.62M3.36B
Pre-Tax Income % of Revenue i11.9%35.5%
Income Tax i29.75M687.00M
Income Tax % of Revenue i3.8%7.3%
Net Income (Profit) i62.87M2.67B
Profit Margin i8.1%28.2%

Balance Sheet & Liquidity Metrics

MetricCOLL (2025)ZTS (2025)
Cash & Equivalents i231.25M2.31B
Total Current Assets i691.41M6.77B
Total Current Assets % of Revenue i88.6%71.5%
Total Current Liabilities i440.03M2.24B
Total Current Liabilities % of Revenue i56.4%23.6%
Long-Term Debt i784.46M9.24B
Long-Term Debt % of Revenue i100.5%97.6%
Total Shareholders Equity i301.68M3.33B
Retained Earnings i-101.13M13.74B
Retained Earnings % of Revenue i-13.0%145.2%
Property, Plant & Equipment i25.77M288.00M

Cash Flow Statement Comparison

MetricCOLL (2025)ZTS (2025)
Operating Cash Flow i329.01M2.78B
Operating Cash Flow % of Revenue i42.2%29.3%
Capital Expenditures i-1.74MN/A
Free Cash Flow i327.58M2.28B
FCF Margin i42.0%24.1%
Debt Repayment i-635.56M-1.35B
Common Stock Repurchase i-25.10M-3.24B

Short Interest & Institutional Ownership Analysis

MetricCOLLZTS
Shares Short i6.03M15.12M
Short Ratio i9.323.60
Short % of Float i22.26%4.06%
Shares Outstanding i31.71M424.93M
Float Shares i31.30M421.29M
% Held by Insiders i0.94%0.15%
% Held by Institutions i120.97%101.50%
% Held by Public i-21.91%-1.65%

Dividend Analysis & Yield Comparison: Collegium Pharmaceutical Inc. vs Zoetis Inc.

MetricCOLLZTS
Last 12-Month Dividend iN/A$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend iN/A$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends iN/A$5.39
Ex-Dividend DateN/AJan 20, 2026